Novel data-mining methodologies for adverse drug event discovery and analysis (Q28681788)

2

0 references

N H Shah

3

0 references

D Madigan

4

0 references

P Ryan

5

0 references

C Friedman

Clinical Pharmacology & Therapeutics

6

0 references

language of work or name

English

0 references

publication date

June 2012

0 references

published in

0 references

volume

91

0 references

issue

6

0 references

page(s)

1010-21

0 references

cites work

DrugBank: a knowledgebase for drugs, drug actions and drug targets

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3675775

The National Center for Biomedical Ontology

17 March 2017

1 reference

https://api.crossref.org/works/10.1038/CLPT.2012.50

Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies

22 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3675775

Annotation Analysis for Testing Drug Safety Signals using Unstructured Clinical Notes

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3675775

Facilitating adverse drug event detection in pharmacovigilance databases using molecular structure similarity: application to rhabdomyolysis.

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3675775

Overcoming barriers to NLP for clinical text: the role of shared tasks and the need for additional creative solutions

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3675775

Detecting drug interactions from adverse-event reports: interaction between paroxetine and pravastatin increases blood glucose levels.

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3675775

Predicting adverse drug reactions using publicly available PubChem BioAssay data

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3675775

Using information mining of the medical literature to improve drug safety

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3675775

Accelerated clinical discovery using self-reported patient data collected online and a patient-matching algorithm

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3675775

Drug repurposing and adverse event prediction using high-throughput literature analysis

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3675775

The implications of propensity score variable selection strategies in pharmacoepidemiology: an empirical illustration.

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3675775

High-Performance Signal Detection for Adverse Drug Events using MapReduce Paradigm.

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3675775

Biclustering of adverse drug events in the FDA's spontaneous reporting system.

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3675775

Mining multi-item drug adverse effect associations in spontaneous reporting systems

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3675775

Advancing the science for active surveillance: rationale and design for the Observational Medical Outcomes Partnership

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3675775

A basic study design for expedited safety signal evaluation based on electronic healthcare data

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3675775

Confounding control in healthcare database research: challenges and potential approaches.

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3675775

Post-approval drug safety surveillance

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3675775

Prediction of drug-related cardiac adverse effects in humans--B: use of QSAR programs for early detection of drug-induced cardiac toxicities

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3675775

A pharmacovigilance program from laboratory signals for the detection and reporting of serious adverse drug reactions in hospitalized patients.

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3675775

Pharmacogenomics of adverse drug reactions: practical applications and perspectives

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3675775

High-dimensional propensity score adjustment in studies of treatment effects using health care claims data

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3675775

Quantitative signal detection using spontaneous ADR reporting

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3675775

Decision support methods for the detection of adverse events in post-marketing data

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3675775

Data-driven methods to discover molecular determinants of serious adverse drug events

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3675775

Early detection of adverse drug events within population-based health networks: application of sequential testing methods.

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3675775

The tell-tale heart: population-based surveillance reveals an association of rofecoxib and celecoxib with myocardial infarction

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3675775

Novel statistical tools for monitoring the safety of marketed drugs

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3675775

The use and misuse of matching in case-control studies: the example of polycystic ovary syndrome

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3675775

Data mining for signals in spontaneous reporting databases: proceed with caution

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3675775

Contrast media and nephropathy: findings from systematic analysis and Food and Drug Administration reports of adverse effects

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3675775

The role of data mining in pharmacovigilance

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3675775

Adverse drug event surveillance and drug withdrawals in the United States, 1969-2002: the importance of reporting suspected reactions

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3675775

A review of uses of health care utilization databases for epidemiologic research on therapeutics

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3675775

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3675775

Disproportionality analysis using empirical Bayes data mining: a tool for the evaluation of drug interactions in the post‐marketing setting

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3675775

Adverse drug event monitoring at the Food and Drug Administration

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3675775

Use of screening algorithms and computer systems to efficiently signal higher-than-expected combinations of drugs and events in the US FDA's spontaneous reports database

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3675775

Risk of acute myocardial infarction and sudden cardiac death in patients treated with cyclo-oxygenase 2 selective and non-selective non-steroidal anti-inflammatory drugs: nested case-control study

3 June 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2012.50

Combining electronic healthcare databases in Europe to allow for large-scale drug safety monitoring: the EU-ADR Project.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2012.50

Identification of structure-activity relationships for adverse effects of pharmaceuticals in humans: Part B. Use of (Q)SAR systems for early detection of drug-induced hepatobiliary and urinary tract toxicities

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2012.50

A Bayesian neural network method for adverse drug reaction signal generation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2012.50

Can network analysis improve pattern recognition among adverse events following immunization reported to VAERS?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2012.50

Methods for drug safety signal detection in longitudinal observational databases: LGPS and LEOPARD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2012.50

Safety surveillance of longitudinal databases: methodological considerations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2012.50

Design considerations in an active medical product safety monitoring system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2012.50

An evaluation of three signal-detection algorithms using a highly inclusive reference event database.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2012.50

Disproportionality methods for pharmacovigilance in longitudinal observational databases

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3675775

Adverse drug events in hospitalized patients. Excess length of stay, extra costs, and attributable mortality.

27 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3675775

Predicting adverse drug events using pharmacological network models

27 November 2018

1 reference

12 December 2020

Estimating treatment effects using observational data

1 reference

12 December 2020

Drug safety reform at the FDA--pendulum swing or systematic improvement?

1 reference

12 December 2020

Managing drug-risk information--what to do with all those new numbers

1 reference

12 December 2020

What can we really learn from observational studies?: the need for empirical assessment of methodology for active drug safety surveillance and comparative effectiveness research

1 reference

12 December 2020

The New Sentinel Network — Improving the Evidence of Medical-Product Safety

1 reference

12 December 2020

Accounting for multiplicities in assessing drug safety: a three-level hierarchical mixture model

1 reference

12 December 2020

Mining association rules between sets of items in large databases

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2012.50

7 January 2021

inferred from DOI database lookup

Identifiers

DOI

10.1038/CLPT.2012.50

1 reference

618066

618066

1 reference

1 reference

1 reference